Business, energy, technology, markets and global industry news from Business News Today

Lupin

Pharma & Biotech

Lupin’s VISUfarma gets exclusive European YUVEZZI rights as presbyopia eye drops become a competitive category

Lupin’s VISUfarma will handle YUVEZZI regulation and commercialization across the EU, UK and selected European markets, while Tenpoint receives an investment, milestones and tiered royalties.

Read More